Benitec Biopharma (BNTC) Current Assets (2019 - 2025)

Benitec Biopharma (BNTC) has 7 years of Current Assets data on file, last reported at $189.6 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets rose 140.87% year-over-year to $189.6 million; the trailing twelve-month figure through Dec 2025 stood at $189.6 million (up 140.87% YoY), and the FY2025 full-year result was $98.5 million, up 90.65% from the prior year.
• Current Assets advanced to $189.6 million in Q4 2025, from $95.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $189.6 million in Q4 2025 to a low of $3.7 million in Q2 2023.
• A 5-year average of $43.1 million and a median of $18.8 million in 2021 frame the typical range for Current Assets.
• Across the five-year window, Current Assets slumped 76.61% in 2022 and soared 1285.73% in 2024, its largest moves.
• Tracing BNTC's Current Assets over 5 years: stood at $12.7 million in 2021, then fell by 13.39% to $11.0 million in 2022, then jumped by 89.49% to $20.8 million in 2023, then soared by 278.5% to $78.7 million in 2024, then jumped by 140.87% to $189.6 million in 2025.
• Business Quant data shows BNTC's Current Assets at $189.6 million in Q4 2025, $95.1 million in Q3 2025, and $98.5 million in Q2 2025.